vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $61.3M, roughly 1.0× Atlanta Braves Holdings, Inc.). Atlanta Braves Holdings, Inc. runs the higher net margin — -67.6% vs -70.9%, a 3.3% gap on every dollar of revenue. On growth, Atlanta Braves Holdings, Inc. posted the faster year-over-year revenue change (17.6% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
BATRA vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.3M | $62.1M |
| Net Profit | $-41.4M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | -81.2% | -9.0% |
| Net Margin | -67.6% | -70.9% |
| Revenue YoY | 17.6% | 8.1% |
| Net Profit YoY | -116.7% | -557.1% |
| EPS (diluted) | $-0.64 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.3M | $62.1M | ||
| Q3 25 | $311.5M | $52.3M | ||
| Q2 25 | $312.4M | $45.6M | ||
| Q1 25 | $47.2M | $41.5M | ||
| Q4 24 | $52.1M | $57.5M | ||
| Q3 24 | $290.7M | $51.5M | ||
| Q2 24 | $282.9M | $46.6M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | $-41.4M | $-44.1M | ||
| Q3 25 | $30.0M | $-5.5M | ||
| Q2 25 | $29.5M | $-5.6M | ||
| Q1 25 | $-41.4M | $-11.4M | ||
| Q4 24 | $-19.1M | $9.6M | ||
| Q3 24 | $10.0M | $941.0K | ||
| Q2 24 | $29.1M | $-10.4M | ||
| Q1 24 | — | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | -81.2% | -9.0% | ||
| Q3 25 | 12.5% | -17.6% | ||
| Q2 25 | 13.4% | -23.3% | ||
| Q1 25 | -94.2% | -36.1% | ||
| Q4 24 | -35.8% | 5.2% | ||
| Q3 24 | 2.2% | -8.2% | ||
| Q2 24 | 8.8% | -18.3% | ||
| Q1 24 | — | -23.9% |
| Q4 25 | -67.6% | -70.9% | ||
| Q3 25 | 9.6% | -10.5% | ||
| Q2 25 | 9.4% | -12.2% | ||
| Q1 25 | -87.7% | -27.5% | ||
| Q4 24 | -36.7% | 16.8% | ||
| Q3 24 | 3.4% | 1.8% | ||
| Q2 24 | 10.3% | -22.4% | ||
| Q1 24 | — | -13.8% |
| Q4 25 | $-0.64 | — | ||
| Q3 25 | $0.47 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $-0.66 | — | ||
| Q4 24 | $-0.29 | — | ||
| Q3 24 | $0.16 | — | ||
| Q2 24 | $0.46 | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $90.9M |
| Total DebtLower is stronger | $738.6M | — |
| Stockholders' EquityBook value | $526.0M | $341.7M |
| Total Assets | $1.6B | $461.5M |
| Debt / EquityLower = less leverage | 1.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.9M | $90.9M | ||
| Q3 25 | $82.2M | $93.3M | ||
| Q2 25 | $96.2M | $75.5M | ||
| Q1 25 | $244.7M | $95.3M | ||
| Q4 24 | $110.1M | $98.7M | ||
| Q3 24 | $100.9M | $162.3M | ||
| Q2 24 | $121.2M | $177.9M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | $738.6M | — | ||
| Q3 25 | $759.9M | — | ||
| Q2 25 | $703.1M | — | ||
| Q1 25 | $699.5M | — | ||
| Q4 24 | $617.1M | — | ||
| Q3 24 | $640.1M | — | ||
| Q2 24 | $600.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | $526.0M | $341.7M | ||
| Q3 25 | $560.3M | $378.6M | ||
| Q2 25 | $522.8M | $377.6M | ||
| Q1 25 | $486.1M | $379.6M | ||
| Q4 24 | $524.2M | $395.7M | ||
| Q3 24 | $530.4M | $385.5M | ||
| Q2 24 | $512.7M | $389.1M | ||
| Q1 24 | — | $392.6M |
| Q4 25 | $1.6B | $461.5M | ||
| Q3 25 | $1.7B | $494.9M | ||
| Q2 25 | $1.7B | $493.3M | ||
| Q1 25 | $1.7B | $482.6M | ||
| Q4 24 | $1.5B | $499.5M | ||
| Q3 24 | $1.6B | $491.2M | ||
| Q2 24 | $1.6B | $483.7M | ||
| Q1 24 | — | $492.1M |
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | 0.0% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | $-771.0K | ||
| Q3 25 | $-88.8M | $-3.9M | ||
| Q2 25 | $-8.1M | $108.0K | ||
| Q1 25 | $95.8M | $-125.0K | ||
| Q4 24 | $28.9M | $2.0M | ||
| Q3 24 | $-69.0M | $13.2M | ||
| Q2 24 | $-34.3M | $6.2M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | $-82.3M | $-1.5M | ||
| Q1 25 | $76.3M | $-974.0K | ||
| Q4 24 | $16.8M | $1.1M | ||
| Q3 24 | $-85.5M | $12.2M | ||
| Q2 24 | $-64.1M | $5.2M | ||
| Q1 24 | — | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | -26.3% | -3.2% | ||
| Q1 25 | 161.5% | -2.3% | ||
| Q4 24 | 32.3% | 1.9% | ||
| Q3 24 | -29.4% | 23.7% | ||
| Q2 24 | -22.7% | 11.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 23.7% | 3.5% | ||
| Q1 25 | 41.3% | 2.0% | ||
| Q4 24 | 23.2% | 1.6% | ||
| Q3 24 | 5.7% | 2.0% | ||
| Q2 24 | 10.5% | 2.3% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | — | ||
| Q2 25 | -0.28× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | -6.89× | 14.05× | ||
| Q2 24 | -1.18× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
